1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Function
4.4. Function Value Chain Analysis
5. Global Nuclear Medicine Market Analysis, By Application
5.1. Introduction
5.2. Diagnosis
5.3. Therapeutic
6. Global Nuclear Medicine Market Analysis, By Procedures
6.1. Introduction
6.2. PET Scan
6.3. SPECT Scan
6.4. Radioimmunotherapy
6.5. Thyroid Ablation
6.6. Brachytherapy
6.7. Others
7. Global Nuclear Medicine Market Analysis, By End-users
7.1. Introduction
7.2. Hospitals
7.3. Diagnostic Centers
7.4. Research Institutes
8. Global Nuclear Medicine Market Analysis, By Geography
8.1. Introduction
8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. UK
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Israel
8.5.2. Saudi Arabia
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Taiwan
8.6.6. Thailand
8.6.7. Indonesia
8.6.8. Others
9. Competitive Environment and Analysis
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. Company Profiles.
10.1. Bracco Diagnostics, Inc.
10.2. Cambridge Isotope Laboratories, Inc.
10.3. Cardinal Health
10.4. GE Healthcare
10.5. Nordion, Inc.
10.6. Lanthenus Medical Imaging, Inc.
10.7. Koninklijke Philips N.V.
10.8. Digirad Corporation
10.9. Biodex
List of Figures
List of Tables